| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |